SkinVive by Juvederm - Synthetic-fluid tissue reconstructive material, anaesthetic - ARTG 431913
Access comprehensive regulatory information for SkinVive by Juvederm - Synthetic-fluid tissue reconstructive material, anaesthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 431913 and sponsored by Abbvie Pty Ltd, manufactured by Allergan in France. The device registration started on December 22, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
• SkinVive by Juvéderm® is an injectable implant used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity, via intradermal injection. • The presence of lidocaine is meant to to reduce the patient’s pain during treatment.